U.S. flag

An official website of the United States government

NM_001100.4(ACTA1):c.587C>T (p.Thr196Ile) AND Actin accumulation myopathy

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 26, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001988135.4

Allele description [Variation Report for NM_001100.4(ACTA1):c.587C>T (p.Thr196Ile)]

NM_001100.4(ACTA1):c.587C>T (p.Thr196Ile)

Gene:
ACTA1:actin alpha 1, skeletal muscle [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q42.13
Genomic location:
Preferred name:
NM_001100.4(ACTA1):c.587C>T (p.Thr196Ile)
HGVS:
  • NC_000001.11:g.229432299G>A
  • NG_006672.1:g.6798C>T
  • NM_001100.3:c.587C>T
  • NM_001100.4:c.587C>TMANE SELECT
  • NP_001091.1:p.Thr196Ile
  • LRG_429t1:c.587C>T
  • LRG_429:g.6798C>T
  • NC_000001.10:g.229568046G>A
Protein change:
T196I
Links:
dbSNP: rs2102735869
NCBI 1000 Genomes Browser:
rs2102735869
Molecular consequence:
  • NM_001100.4:c.587C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Actin accumulation myopathy (CMYO2A)
Synonyms:
Nemaline myopathy caused by mutation in the alpha-actin gene; CONGENITAL MYOPATHY 2A, TYPICAL, AUTOSOMAL DOMINANT; Myopathy, actin, congenital, with cores; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008070; MedGen: C3711389; OMIM: 161800

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002220856Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Oct 26, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Congenital myopathies in the adult neuromuscular clinic: Diagnostic challenges and pitfalls.

Nicolau S, Liewluck T, Tracy JA, Laughlin RS, Milone M.

Neurol Genet. 2019 Aug;5(4):e341. doi: 10.1212/NXG.0000000000000341.

PubMed [citation]
PMID:
31321302
PMCID:
PMC6563518

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV002220856.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 196 of the ACTA1 protein (p.Thr196Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant congenital myopathy (PMID: 31321302). ClinVar contains an entry for this variant (Variation ID: 1447156). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ACTA1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 29, 2024